Desq Long
Sign in
SEC FORM 4
$36,943.62

Akari Therapeutics Plc (AKTX)

Acquisition (code A) of 4,677 shares at $7.899 per share.

Reporting Person Bazemore Robert B · Transaction Code A

Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS

Source: SEC Form 4 · 0001493152-26-047455 · filed 2026-10-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Akari Therapeutics Plc (AKTX)." Disclosed 2026-10-16. https://desqlong.com/cards/0001493152-26-047455-2 (retrieved 2026-10-17).